Abstract
Once removed from their natural environment, membrane proteins depend on membrane‐mimetic systems to retain their native structures and functions. To this end, lipid‐bilayer nanodiscs that are bounded by scaffold proteins or amphiphilic polymers such as styrene/maleic acid (SMA) copolymers have been introduced as alternatives to detergent micelles and liposomes for in vitro membrane‐protein research. Herein, we show that an alternating diisobutylene/maleic acid (DIBMA) copolymer shows equal performance to SMA in solubilizing phospholipids, stabilizes an integral membrane enzyme in functional bilayer nanodiscs, and extracts proteins of various sizes directly from cellular membranes. Unlike aromatic SMA, aliphatic DIBMA has only a mild effect on lipid acyl‐chain order, does not interfere with optical spectroscopy in the far‐UV range, and does not precipitate in the presence of low millimolar concentrations of divalent cations.
Keywords: amphiphilic polymers, biomembranes, membrane proteins, membrane mimetics, protein chromatography
Integral membrane proteins perform a plethora of cellular functions and are major drug targets.1 Their extraction, purification, and in vitro investigation often remain challenging2 because the hydrophobic transmembrane segments of these proteins dictate the use of amphiphilic compounds that form membrane‐mimetic nanoenvironments to confer solubility in aqueous media. Detergents are traditionally used for solubilization,2 although their micellar assemblies do not adequately reproduce some of the hallmarks of the native lipid‐bilayer environment. Detergent‐purified proteins can be reconstituted into liposomes; however, the large size of liposomes is incompatible with many chromatographic and optical spectroscopic techniques as well as solution NMR spectroscopy. The advent of nanodiscs assembled from phospholipids and membrane‐scaffold proteins (MSPs) marked substantial progress in the development of nanosized lipid‐bilayer particles.3 More recently, styrene/maleic acid (SMA) copolymers (Figure 1 a) have been found to recruit membrane proteins and associated lipids directly from natural or artificial membranes into “native nanodiscs” or SMA/lipid particles (SMALPs).4, 5, 6, 7, 8, 9, 10, 11, 12, 13 Hence, without requiring assistance from conventional detergents, SMA solubilizes and stabilizes a variety of membrane proteins, ranging from bacteriorhodopsin4, 5 to ABC transporters,4, 7 ion channels,6 bacterial reaction centers,8 and G‐protein‐coupled receptors.9, 12
Unfortunately, optical spectroscopic studies on membrane proteins embedded in either MSP nanodiscs or SMALPs are hampered by the strong UV absorption of the disc scaffold, that is, MSP or SMA, respectively (Figure 1 b). Thus, although the direct extraction of membrane proteins into SMALPs presents a number of advantages10, 11, 13 over detergent‐based approaches,2 the amount of protein solubilized by SMA cannot be readily quantified using UV absorbance.6, 11 For the same reason, far‐UV circular dichroism (CD) spectra of proteins in SMALPs can be acquired only after the removal of protein‐free nanodiscs,4, 6, 7, 9, 12 and the presence of phenyl moieties can pose problems during purification steps involving column materials prone to nonspecific interactions with aromatic groups.10, 11, 13 Moreover, SMA precipitates in the presence of low concentrations of divalent cations, which renders it incompatible with many biochemical or functional protein assays that depend on Mg2+ or Ca2+.10, 11, 13 Herein, we address these challenges by demonstrating that a diisobutylene/maleic acid (DIBMA) copolymer (Figure 1 a) efficiently solubilizes lipids and proteins to generate nanodiscs harboring a natively folded and functionally active integral membrane enzyme that is directly amenable to UV spectroscopy as well as a Ca2+‐dependent enzyme activity assay. Our finding that DIBMA is able to extract proteins of largely different sizes from native membranes indicates that this novel solubilizing polymer is applicable to a broad range of target proteins.
DIBMA is an alternating copolymer of maleic acid and diisobutylene (2,4,4‐trimethylpent‐1‐ene) that is commercially available under the trade name Sokalan CP9 (BASF, Germany) with a nominal molar mass of 12 kg mol−1. Buffered DIBMA solutions can readily be prepared from stock solutions through dialysis without laborious precipitation, washing, and lyophilization steps.11, 13 After dialysis, size‐exclusion chromatography (SEC) coupled to refractive‐index and light‐scattering detection yielded a mass‐average molar mass of Mw=15.3 kg mol−1, a number‐average molar mass of Mn=8.4 kg mol−1, and thus a dispersity of Mw/Mn=1.82 (Figure S1 in the Supporting Information). As anticipated, we found the far‐UV extinction coefficient of aliphatic DIBMA to be much lower than that of aromatic SMA (Figure 1 b). We examined the membrane‐solubilizing capacity of DIBMA and the emergence of DIBMA/lipid particles (DIBMALPs) by exposing large unilamellar vesicles (LUVs) made of the phospholipid 1,2‐dimyristoyl‐sn‐glycero‐3‐phosphocholine (DMPC) to increasing polymer concentrations and monitoring nanoparticle formation by dynamic light scattering (DLS), transmission electron microscopy (TEM), and 31P NMR spectroscopy.
Upon addition of DIBMA, the turbidity typical of DMPC LUVs cleared within a few seconds (Figure S2a). Particle size distributions derived from DLS (Figure 2 a, Figure S2b–d) revealed an increase in apparent hydrodynamic diameter from around 150 nm to more than 1000 nm before solubilization set in. Thereafter, the hydrodynamic diameter smoothly decreased to approximately 35 nm at a DIBMA/DMPC molar ratio of 0.08 and further to approximately 18 nm at a ratio of 0.20 (Figure 2 b). Hence, DIBMALPs are somewhat larger than SMALPs, which under comparable conditions have diameters of around 29 nm and 13 nm, respectively.14 DIBMA also proved effective in solubilizing longer‐chain phospholipids such as 1,2‐dipalmitoyl‐sn‐glycero‐3‐phosphocholine (DPPC; Figure S3) and shorter‐chain variants such as 1,2‐dilauroyl‐sn‐glycero‐3‐phosphocholine (DLPC; see Figure 4). Negative‐stain TEM showed DIBMALPs to be homogeneous disc‐shaped particles (Figure 2 c).
In 31P NMR experiments, the signal of slow‐tumbling DMPC LUVs was broadened beyond detection, but an isotropic peak emerged upon addition of DIBMA (Figure 2 d), the intensity of which reflected the amount of solubilized lipid.14, 15 The peak areas at each DMPC concentration revealed two breakpoints marking the onset (SAT) and completion (SOL) of solubilization (Figure 2 e). Plotting the DIBMA concentrations at the SAT and SOL boundaries against the corresponding DMPC concentrations yielded a phase diagram (Figure 2 f) characterized by saturating and solubilizing DIBMA/DMPC molar ratios of 0.030±0.005 and 0.062±0.004, with vanishing ordinate intercepts suggesting a negligible concentration of “free” polymer. From these molar ratios, we derived free‐energy changes accompanying the transfer of DMPC and DIBMA from vesicles into DIBMALPs of (0.077±0.010) kJ mol−1 and −(1.76±0.09) kJ mol−1, respectively. Under similar conditions, DMPC solubilization by SMA(3:1) is described by critical molar ratios of 0.078±0.008 and 0.144±0.014, which correspond to vesicle‐to‐SMALP transfer free energies of (0.15±0.05) kJ mol−1 and −(1.36±0.45) kJ mol−1.14 Such marginal free‐energy penalties incurred upon lipid transfer from vesicular bilayers into both kinds of nanodiscs attest to the gentle nature of lipid solubilization by DIBMA and SMA(3:1).
We compared the effects of DIBMA and SMA(3:1) on the conformational order of phospholipid acyl chains by Raman spectroscopy. Importantly, there were no major differences in the vibrational frequencies or intensities of representative DMPC bands before and after solubilization by DIBMA, either in the gel phase at 10 °C (Figure 3 a) or in the fluid state at 25 °C (Figure 3 b). By contrast, solubilization by SMA(3:1) resulted in significant shifts and intensity reductions in the C−C stretching bands near 1125 cm−1 and 1060 cm−1 as well as the methylene twisting mode near 1300 cm−1, particularly at 10 °C (Figure 3 a) but also at 25 °C (Figure 3 b). These observations are ascribed to a loss in acyl‐chain order as the number of gauche defects increases16, 17 upon SMALP formation, whereas vesicle‐like chain order is preserved in DIBMALPs in both phase states of DMPC.
We further compared the distinct effects of the two polymers by monitoring the thermotropic phase transition of DMPC with the aid of differential scanning calorimetry (DSC). DMPC LUVs gave rise to a sharp gel‐to‐fluid transition at 24 °C. Upon solubilization by DIBMA or SMA(3:1), the transition became broader (Figure 3 c, Figure S4a,b), thus indicating the existence of bilayer structures of smaller size.18, 19 The calorimetric enthalpy decreased from 1.5 kJ mol−1 in LUVs to 1.0 kJ mol−1 and 0.84 kJ mol−1 in DIBMALPs and SMALPs, respectively, while the van't Hoff enthalpy was reduced from approximately 94 kJ mol−1 to approximately 15 kJ mol−1 in both cases. Thus, the “cooperative unit”, taken as the ratio of the van't Hoff enthalpy to the calorimetric enthalpy, diminished from more than 60 lipid molecules in LUVs to fewer than 25 lipids in both types of nanodiscs (Figure S4c). While the reduced cooperativity reflects the nanoscale size of DIBMALPs and SMALPs, the decrease in calorimetric enthalpy must result from a fraction of DMPC being in contact with the polymer scaffolds along the rim of the nanodiscs. In sharp contrast with the situation encountered in SMALPs, the transition temperature was not downshifted upon solubilization by moderate DIBMA concentrations (Figure 3 d). This suggests much less perturbation of lipid packing by DIBMA compared with SMA(3:1), the stronger effect of which is thought to result from intrusion of its phenyl rings into the bilayer core.19, 20 With DIBMALPs, similarly low transition temperatures of around 10 °C were reached only at much higher polymer/lipid ratios (Figure S4d). The gentle solubilizing properties of the branched aliphatic side chain of DIBMA may have important implications for stabilizing and studying membrane proteins with functions that depend on lipid order and dynamics.21
The ability of DIBMA to solubilize an integral membrane protein was tested on DLPC proteoliposomes containing outer membrane phospholipase A (OmpLA)22 and, for comparison, protein‐free DLPC liposomes. Solubilization of the proteoliposomes yielded sharp 31P NMR peaks (Figure 4 a) and was as efficient as in the absence of protein (Figure 4 b). At a DIBMA/DLPC molar ratio of 0.20, both protein‐free and OmpLA‐loaded DIBMALPs were found to be disc‐shaped particles with diameters of approximately 15 nm (Figure 4 c–e). Crucially, OmpLA fully retained its enzymatic activity in DIBMALPs (Figure 4 f), which remained in suspension without any signs of aggregation or precipitation upon Ca2+‐mediated phospholipase activation. Of note, enzyme assays of OmpLA in SMALPs failed because the latter precipitated with as little as 2 mm Ca2+ (Figure S5a), whereas DIBMALPs were found to tolerate at least 20 mm Ca2+ (Figure S5b) or Mg2+ (Figure S6).
The absence of UV‐absorbing groups in DIBMA allowed us to utilize CD spectroscopy to assess the secondary structure and stability of OmpLA in DIBMALPs without the prior removal of protein‐free nanodiscs. Folded OmpLA exhibited a CD maximum at 232 nm and a pronounced minimum at 218 nm, which are typical of high β‐strand content.22 In DIBMALPs, OmpLA retained these spectral characteristics even in the presence of high urea concentrations (Figure 4 g) and at elevated temperatures (Figure S7a), thus demonstrating that DIBMALPs impart considerable conformational stability to the protein, as has been shown for OmpLA in vesicular lipid bilayers.23 By contrast, no CD spectra could be obtained from OmpLA in unpurified SMALPs (Figure S7b) because of the prohibitively strong UV absorption of the SMA scaffold. This agrees with earlier reports4, 6, 7, 9, 12 that proteins in SMALPs are amenable to UV spectroscopy only after the removal of protein‐free nanodiscs. Although the latter can be achieved by chromatographic purification,11, 13 there are considerable advantages to extracting membrane proteins into an environment that immediately enables reliable concentration determination by UV absorbance as well as deeper scrutiny by optical spectroscopic techniques such as far‐UV CD24 prior to any further treatment. Furthermore, the small particle size and narrow size distribution of DIBMALPs were maintained even under strongly denaturing conditions (Figure 4 h), which contrasts with the drastic effects of chaotropes on the size and morphology of detergent micelles25 and MSP nanodiscs.26
To demonstrate the compatibility of DIBMALPs with protein‐chromatographic methods, we subjected samples produced by solubilizing proteoliposomes with various DIBMA concentrations to SEC. Elution profiles revealed a first peak corresponding to DIBMALPs that contained OmpLA and a second peak reflecting protein‐free nanodiscs (Figure 5 a). After SEC purification, OmpLA‐containing DIBMALPs appeared as homogeneously sized particles with a diameter of approximately 20 nm at a DIBMA/DLPC molar ratio of 0.10, which further diminished to around 12 nm at a ratio of 0.25 (Figure 5 b). OmpLA remained natively folded after SEC, as confirmed by cold sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‐PAGE; Figure 5 c). While heat‐denatured OmpLA migrated as expected for an unfolded polypeptide of 31 kg mol−1, unboiled samples exhibited an apparent molar mass of 17 kg mol−1, as previously shown for the native enzyme.24
Finally, we wondered whether DIBMA could extract integral membrane proteins from native membranes of Escherichia coli, the “workhorse” of heterologous protein production. In terms of solubilizing total membrane‐protein mass, the efficiency of DIBMA relative to that of the gold‐standard detergent n‐dodecyl‐β‐d‐maltopyranoside (DDM) amounted to around 70 % at both pH values tested (Figure 6). For comparison, SMA(3:1) showed relative efficiencies of around 80 % at pH 8.3 and 60 % at pH 7.4. While DIBMA, SMA(3:1), and DDM solubilized various proteins to different extents, there were striking similarities among the overall SDS‐PAGE patterns. Comparison with the total protein patterns of inner and outer E. coli membranes27, 28 indicates that DIBMA and SMA(3:1) can extract a wide range of membrane proteins from both bacterial membranes. Notably, polymer‐mediated protein solubilization directly from the outer membrane has not otherwise been reported so far.10
In summary, we have demonstrated that DIBMA is a valuable addition to the small repertoire of amphiphilic polymers that are capable of extracting membrane proteins from cellular or model membranes to accommodate them in lipid‐bilayer nanodiscs. DIBMALPs are chemically and thermally stable, have a narrow size distribution, and support the activity of an integral membrane enzyme. Unlike other nanodisc scaffolds, DIBMA has only a mild impact on lipid acyl‐chain order, is compatible with far‐UV spectroscopy without the prior removal of empty nanodiscs, and tolerates fairly high concentrations of divalent cations, which offers substantial advantages for in vitro studies on integral membrane proteins in a nanosized lipid‐bilayer environment.
Conflict of interest
The authors declare no conflict of interest.
Supporting information
Acknowledgements
We thank Dr. Harald Kelm (University of Kaiserslautern) and Dr. Markus Epe and Dr. Samir Safi (Malvern Instruments) for assistance with NMR and Raman spectroscopy, respectively. Dr. Jana Broecker and Dr. Sebastian Fiedler (University of Toronto), Dr. Andreas Kerth (Martin Luther University Halle‐Wittenberg), and Rodrigo Cuevas Arenas, Erik Frotscher, Dr. Katharina Gimpl, Anne Grethen, Jessica Klement, and Johannes Klingler (University of Kaiserslautern) are gratefully acknowledged for helpful discussions. This work was partly funded by the Deutsche Akademische Austauschdienst (DAAD) with grant no. 57052629 to A.O.O. and by the Deutsche Forschungsgemeinschaft (DFG) through International Research Training Group (IRTG) 1830.
A. O. Oluwole, B. Danielczak, A. Meister, J. O. Babalola, C. Vargas, S. Keller, Angew. Chem. Int. Ed. 2017, 56, 1919.
References
- 1. Overington J. P., Al-Lazikani B., Hopkins A. L., Nat. Rev. 2006, 5, 993–996. [DOI] [PubMed] [Google Scholar]
- 2. Bordag N., Keller S., Chem. Phys. Lipids 2010, 163, 1–26. [DOI] [PubMed] [Google Scholar]
- 3. Bayburt T. H., Sligar S. G., FEBS Lett. 2010, 584, 1721–1727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Knowles T. J., Finka R., Smith C., Lin Y., Dafforn T., Overduin M., J. Am. Chem. Soc. 2009, 131, 7484–7485. [DOI] [PubMed] [Google Scholar]
- 5. Orwick-Rydmark M., Lovett J. E., Graziadei A., Lindholm L., Hicks M. R., Watts A., Nano Lett. 2012, 12, 4687–4692. [DOI] [PubMed] [Google Scholar]
- 6. Dörr J. M., Koorengevel M. C., Schäfer M., Prokofyev A. V., Scheidelaar S., van der Cruijsen W., Dafforn T. R., Baldus M., Killian J. A., Proc. Natl. Acad. Sci. USA 2014, 111, 18607–18612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Gulati S., Jamshad M., Knowles T. J., Morrison K. A., Downing R., Cant N., Collins R., Koendrick J. B., Ford R. C., Overduin M., Kerr I., Dafforn T. R., Rothnie A. J., Biochem. J. 2014, 461, 269–278. [DOI] [PubMed] [Google Scholar]
- 8. Swainsbury D. J. K., Scheidelaar S., van Grondelle R., Killian J. A., Jones M. R., Angew. Chem. Int. Ed. 2014, 53, 11803–11807; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2014, 126, 11997–12001. [Google Scholar]
- 9. Jamshad M., Charlton J., Lin Y., Routledge S. J., Bawa Z., Knowles T. J., Overduin M., Dekker N., Dafforn T. R., Bill R. M., Poyner D. R., Wheatley M., Biosci. Rep. 2015, 35, e00188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Dörr J. M., Scheidelaar S., Koorengevel M. C., Dominguez J. J., Schäfer M., van Walree C. A., Killian J. A., Eur. Biophys. J. 2016, 45, 3–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Lee S. C., Knowles T. J., Postis V. L. G., Jamshad M., Parslow R. A., Lin Y., Goldman A., Sridhar P., Overduin M., Muench S. P., Dafforn T. R., Nat. Protoc. 2016, 11, 1149–1162. [DOI] [PubMed] [Google Scholar]
- 12. Logez C., Damian M., Legros C., Dupré C., Guery M., Mary S., Wagner R., M'Kadmi C., Nosjean O., Fould B., Marie J., Fehrentz J., Martinez J., Ferry G., Boutin J. A., Banères J.-L., Biochemistry 2016, 55, 38–48. [DOI] [PubMed] [Google Scholar]
- 13. Rothnie A. J., Methods Mol. Biol. 2016, 1432, 261–267. [DOI] [PubMed] [Google Scholar]
- 14. Cuevas Arenas R., Klingler J., Vargas C., Keller S., Nanoscale 2016, 8, 15016–15026. [DOI] [PubMed] [Google Scholar]
- 15. Vargas C., Cuevas Arenas R., Frotscher E., Keller S., Nanoscale 2015, 7, 20685–20696. [DOI] [PubMed] [Google Scholar]
- 16. Wong P. T., Annu. Rev. Biophys. Bioeng. 1984, 13, 1–24. [DOI] [PubMed] [Google Scholar]
- 17. Orendorff C. J., Ducey M. W., Pemberton J. E., J. Phys. Chem. A 2002, 106, 6991–6998. [DOI] [PubMed] [Google Scholar]
- 18. Orwick M. C., Judge P. J., Procek J., Lindholm L., Graziadei A., Engel A., Gröbner G., Watts A., Angew. Chem. Int. Ed. 2012, 51, 4653–4657; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2012, 124, 4731–4735. [Google Scholar]
- 19. Jamshad M., Grimard V., Idini I., Knowles T. J., Dowle M. R., Schofield N., Sridhar P., Lin Y., Finka R., Wheatley M., Thomas O. R. T., Palmer R. E., Overduin M., Govaerts C., Ruysschaert J., Edler K. J., Dafforn T. R., Nano Res. 2015, 8, 774–789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Scheidelaar S., Koorengevel M. C., Pardo J. D., Meeldijk J. D., Breukink E., Killian J. A., Biophys. J. 2015, 108, 279–290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Lundbæk J. A., Collingwood S. A., Ingólfsson H. I., Kapoor R., Andersen O. S., J. R. Soc. Interface 2010, 7, 373–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Dekker N., Merck K., Tommassen J., Verheij H. M., Eur. J. Biochem. 1995, 232, 214–219. [DOI] [PubMed] [Google Scholar]
- 23. Moon C. P., Kwon S., Fleming K. G., J. Mol. Biol. 2011, 413, 484–494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Fiedler S., Cole L., Keller S., Anal. Chem. 2013, 85, 1868–1872. [DOI] [PubMed] [Google Scholar]
- 25. Broecker J., Keller S., Langmuir 2013, 29, 8502–8510. [DOI] [PubMed] [Google Scholar]
- 26. Handa D., Kimura H., Oka T., Takechi Y., Okuhira K., Phillips M. C., Saito H., Biochemistry 2015, 54, 1123–1131. [DOI] [PubMed] [Google Scholar]
- 27. Duquesne K., Sturgis J. N., Methods Mol. Biol. 2010, 601, 205–217. [DOI] [PubMed] [Google Scholar]
- 28. Arachea B. T., Sun Z., Potente N., Malik R., Isailovic D., Viola R. E., Protein Expression Purif. 2012, 86, 12–20. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.